Preferred Label : Bimatoprost;

MeSH definition : A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.;

MeSH hyponym : lumigan; AGN 192024; Latisse; 192024, AGN;

MeSH CAS label : 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-;

MeSH Related Number : 155206-00-1;

Wikipedia link : https://en.wikipedia.org/wiki/Bimatoprost;

Is substance : O;

UNII : QXS94885MZ;

Details


Main resources

You can consult :

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

https://www.has-sante.fr/jcms/p_3399888/fr/bimatoprost-teva-sante-bimatoprost-glaucome
2022
false
false
false
France
ocular hypertension
treatment outcome
insurance, health, reimbursement
bimatoprost
administration, ophthalmic
adult
ophthalmic solutions
evaluation of the transparency committee
glaucoma, open-angle
Bimatoprost

---
https://www.has-sante.fr/jcms/p_3333937/fr/amiriox-bimatoprost
2022
false
false
false
France
evaluation of the transparency committee
Bimatoprost

---
https://www.has-sante.fr/jcms/p_3326694/fr/ecbirio-timolol-/-bimatoprost
2022
false
false
false
France
drug combinations
administration, ophthalmic
adult
glaucoma, open-angle
ocular hypertension
timolol, combinations
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee
timolol
Bimatoprost

---
https://www.has-sante.fr/jcms/p_3292175/fr/bimatoprost-idifarma-0-3-mg/ml-bimatoprost
2021
false
false
false
France
Bimatoprost
insurance, health, reimbursement
treatment outcome
administration, ophthalmic
bimatoprost
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2913085/fr/lumigan
2019
true
false
France
French
Bimatoprost
glaucoma
miotics
Bimatoprost
ophthalmic solutions
bimatoprost
insurance, health, reimbursement
antihypertensive agents
adult
glaucoma, open-angle
chronic disease
ocular hypertension
treatment outcome
administration, ophthalmic
evaluation of the transparency committee

---
Renouvellement d'inscription
https://www.has-sante.fr/portail/jcms/c_2908649/fr/ganfort
2019
true
false
France
French
ganfort
evaluation of the transparency committee
Bimatoprost
ophthalmic solutions
drug combinations
amides
cloprostenol
antihypertensive agents
timolol maleate
adrenergic beta-antagonists
timolol
insurance, health, reimbursement
glaucoma, open-angle
ocular hypertension
timolol, combinations
administration, ophthalmic
amides

---
https://www.has-sante.fr/portail/jcms/c_2886955/fr/bimatoprost/timolol-chauvin
2018
false
true
false
France
Bimatoprost
drug combinations
timolol maleate
administration, ophthalmic
adult
glaucoma, open-angle
ocular hypertension
timolol, combinations
evaluation of the transparency committee
timolol

---
http://www.has-sante.fr/portail/jcms/c_1774640/fr/ganfort
2014
true
France
French
Single Dose Vial
ganfort
evaluation of the transparency committee
Bimatoprost
ophthalmic solutions
drug combinations
amides
cloprostenol
antihypertensive agents
timolol maleate
adrenergic beta-antagonists
timolol
insurance, health, reimbursement
glaucoma, open-angle
ocular hypertension
timolol, combinations
administration, ophthalmic

---
http://www.has-sante.fr/portail/jcms/c_1603407/fr/lumigan
http://www.has-sante.fr/portail/jcms/c_1603406/fr/lumigan-29052013-avis-ct12839
2013
false
France
French
Bimatoprost
Bimatoprost
evaluation of the transparency committee
ophthalmic solutions
administration, ophthalmic
insurance, health, reimbursement
antihypertensive agents
antihypertensive agents
bimatoprost
Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug)
glaucoma, open-angle
ocular hypertension
treatment outcome
clinical trials, phase iii as topic

---
http://www.lecrat.eu/?s=Bimatoprost
2013
false
France
French
Bimatoprost
pregnancy
glaucoma
antihypertensive agents
breast feeding
bimatoprost
drug information

---
https://www.ema.europa.eu/medicines/human/EPAR/Lumigan
2012
false
United Kingdom
French
English
syndication feed
Bimatoprost
Bimatoprost
ocular hypertension
glaucoma, open-angle
chronic disease
drug therapy, combination
treatment outcome
ophthalmic solutions
drug interactions
pregnancy
breast feeding
drug approval
drug evaluation, preclinical
drug labeling
aged
adult
antihypertensive agents
bimatoprost
administration, ophthalmic
drug evaluation
package leaflet
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Ganfort
2012
false
United Kingdom
French
English
syndication feed
ganfort
ganfort
Bimatoprost
Bimatoprost
glaucoma, open-angle
ocular hypertension
timolol
timolol
adrenergic beta-antagonists
adrenergic beta-antagonists
antihypertensive agents
antihypertensive agents
treatment outcome
drug evaluation
drug combinations
drug labeling
drug approval
ophthalmic solutions
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
timolol, combinations
timolol maleate
timolol maleate
administration, ophthalmic
package leaflet
drug evaluation
summary of product characteristics
amides
cloprostenol
cloprostenol
drug combinations
amides
cloprostenol
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_944580/lumigan
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/lumigan_06062012_avis_ct12024.pdf
http://www.has-sante.fr/portail/jcms/c_1260381/lumigan
http://www.has-sante.fr/portail/display.jsp?id=c_490465
http://www.has-sante.fr/portail/display.jsp?id=c_400049
http://www.has-sante.fr/portail/display.jsp?id=c_399437
2012
false
France
French
Bimatoprost
drug therapy, combination
ophthalmic solutions
instillation, drug
bimatoprost
insurance, health, reimbursement
antihypertensive agents
adult
glaucoma, open-angle
chronic disease
ocular hypertension
treatment outcome
administration, ophthalmic
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1231626/ganfort
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/ganfort_29022012_avis_ct10497.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_460037
2012
false
France
French
evaluation of the transparency committee
Bimatoprost
ganfort
ophthalmic solutions
drug combinations
amides
cloprostenol
antihypertensive agents
timolol maleate
adrenergic beta-antagonists
timolol
insurance, health, reimbursement
glaucoma, open-angle
ocular hypertension
timolol, combinations
administration, ophthalmic
drug combinations

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.